BGI and MGI, leading suppliers of COVID-19 test kits and automated sample preparation system, have launched a new Clinical Lab Partnership Program to expand our CLIA/CAP lab network. The Program is designed to empower your lab with our readily available trusted lab supplies as well as our commercial and technical support so you can focus on maximizing lab productivity and delivering test results. Our partner labs enjoy many more exclusive benefits than regular labs. Join our lab partnership network today to fuel your future growth.
We have built and secured an abundant supply of kits for sample collection, RNA extraction and RT-PCR testing. Our manufacturing capacity expansion and streamlined distribution enable us to supply these critical items without any back-logs.
BEST-IN-CLASS LAB SOLUTION
Our total lab solution is a proven, integrated workflow. It has received global regulatory approvals or emergency use authorizations, and has shown to outperform in clinical sensitivity. Your program participation will provide you early access to our future COVID-19 products and technologies.
SUSTAINABLE TEST VOLUME
We are committed to ramping up your test volume by customer referral. In return, you receive more favorable service terms and product pricing. Our high-throughput automated sample preparation system will significantly improve your testing efficiency and reproducibility.
PREMIER SALES AND CUSTOMER SUPPORT
You can count on our established commercial infra-structure and other resources for enhanced sales/marketing and customer support. We will support your Request For Proposal (RFP) submissions to secure new testing contracts.
Profile of Partner Labs
“Working with BGI/MGI was the obvious choice for us because of BGI’s full test solution and control of their supply chain.”
–Task Force Lab
Founding Partner, BGI/MGI Clinical Lab Partnership Program
Request a quote and your BGI representative will reply to you within 24 hours.